Background {#Sec1}
==========

Acute respiratory tract infection (RTI) is estimated to be the second important cause of death throughout the world among children less than 5 years old \[[@CR1]\]. Both respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) are important viral pathogens inducing RTI \[[@CR2]--[@CR4]\]. RSV and hMPV are non-segmented, negative-strand, enveloped RNA viruses. Both of them are classified within the Pneumovirinae subfamily of the Paramyxoviridae family. RSV is implicated in the majority of respiratory tract infection, which accounts for 60--80% of the bronchiolitis cases in children below 12 months of age \[[@CR5]\]. Recently, it has been demonstrated that hMPV also causes acute respiratory tract infections, similar to RSV \[[@CR1], [@CR6]\]. hMPV was first identified in 2001 from a pediatric patient with respiratory diseases in the Netherlands \[[@CR7]\]. hMPV causes a wide spectrum of disease ranging from mild upper RTI to more severe lower RTI such as bronchiolitis or pneumonia. Second to RSV, hMPV causes bronchiolitis and accounts for 5--15% of child hospitalizations for RTI \[[@CR8], [@CR9]\].

Both RSV and hMPV infections induce disruption of respiratory epithelial architecture, sloughing of epithelial cells, loss of cilation and acute pulmonary inflammation characterized by alveolitis, interstitial inflammation and peribronchiolitis \[[@CR7], [@CR9]\]. Following, acute otitis media is the most common complication of RTI due to RSV or hMPV \[[@CR8]\]. At present, the initial clinical manifestations of RSV are indistinguishable from those of hMPV \[[@CR10]--[@CR12]\]. One possible reference to distinguish RSV and hMPV infections is based on the epidemiological data. The median age of hMPV-positive hospitalized patients is 6-12 months, which is significantly higher than that of RSV (2-3 months) \[[@CR13]\].

RSV and hMPV do not appear to be significantly associated with asymptomatic carriage in the respiratory tract of healthy persons. However, the diagnosis efficiency for these 2 virus infection is low using the classical virus culture methods. Both viruses are labile in the environment and are susceptible to drying \[[@CR14]\]. For viral culture, RSV can growth in the HEp-2, A549, or Vero cells and usually takes 3--5 days to revealing characteristic syncytial cytopathic pattern \[[@CR7], [@CR15]--[@CR17]\]. In contrast, hMPV can growth in the LLC-MK2 cells. The growth of hMPV is slow and often requires several blind passages before any cytopathic effect (CPE) is apparent, particularly following primary isolation, which often takes more than 10 days \[[@CR18]\]. These lengthy viral culture processes, in part, limited the opportunity for optimal initial diagnosis and the following therapeutic adjustment for RTI patient. Therefore, a reliable and rapid diagnostic tool is needed. Rapid and accurate laboratory diagnosis of viral RTI is crucial for optimal clinical management, diminishes unnecessary use of antibiotics, and allows for use of antivirals when appropriate.

Objectives {#Sec2}
==========

The aim of this study is to design and assess the diagnostic performance of clinical specimens for the simultaneous identification of RSV and hMPV by using one-step triplex qRT-PCR assay with TaqMan probes. To this aim, we first performed our primer and probe design. Then we used cultured viruses to evaluate the specificity of our primers using qRT-PCR. Finally, we used this established qRT-PCR assay to detect the viral load in nasopharyngeal aspirates.

Methods {#Sec3}
=======

Primers and probe design {#Sec4}
------------------------

The primers and probes for RSV, hMPV and GAPDH were designed by Primer 3 website (<http://bioinfo.ut.ee/primer3-0.4.0/primer3/>). We selected RSV nucleoprotein gene conserved regions as a target for our RSV primer and probe designs. For hMPV, we selected hMPV fusion protein gene conserved regions as a target for our primer and probe designs. The target sequence of our primer and probe designs was showed in Table [1](#Tab1){ref-type="table"}. The specificity of these primer and probe sequences were tested by the BLAST algorithm.Table 1Design of the one-step triplex qRT-PCR assays for the detection of RSV, hMPV and Internal ControlVirusTarget geneName of primer or probeSequence (5′ → 3′)PositionRSVNucleoproteinRSV-FTGATACACTSAACAAAGATCAACTTCTG27--54^a^RSV-RTCTCCTGTGCTMCGTTGRAT73--92^a^RSV-probeVIC-CATCCAGCAAATACAC-MGBNFQ56--71^a^hMPVFusion proteinhMPV-FTCAGAATGCAGGGTCAACTGTT156--177^b^hMPV-RGACATGGTCTCCTCTTGTTTCACA199--222^b^hMPV-probeFAM-CAAGCTTCCCGTTCTCAGCC-MGBNFQ179--197^b^Internal ControlGAPDHGAPDH-FGAAGGTGAAGGTCGGAGTC108--126^c^GAPDH-RGAAGATGGTGATGGGATTTC314--333^c^GAPDH-probeNED-CAAGCTTCCCGTTCTCAGCC-MGBNFQ285--304^ca^GenBank Accession no. DQ780565.1^b^GenBank Accession no. AY295956.1^c^GenBank Accession no. NM_002046

To rapidly and accurately quantify the RSV and hMPV in nasopharyngeal aspirates, we combined 3 single qRT-PCR, amplifying RSV, hMPV and GAPDH (internal control), in a one-tube reaction. For this one-tube reaction, the probe for RSV was labeled with the dye VIC dye at its 5′ end and minor groove binder (MGB) at its 3′end. The probe for hMPV was labeled with the reporter 6-carboxyfluorescein (FAM) dye at its 5′ end and MGB at its 3′ end. The probe for GAPDH was labeled with NED dye at its 5′ end and MGB at its 3′ end. RSV, hMPV and GAPDH amplification signals were separately detected by the VIC, FAM and NED channels by multi-channel qRT-PCR detection system. The primers for direct sequencing as described following: hMPV-F: 5′-CAACTGTTTACTACCCAAATGA-3′, hMPV-R: 5′-ATAGGGTGTCTTCCTGTGC-3′; RSV-F: 5′-TTAACCAGCAAAGTGTTAGAYCTCAA-3′, RSV-R: 5′-CTGRTCATTTGTTATRGGCATATCATTG-3′.

Virus culture and immunofluorescence assay {#Sec5}
------------------------------------------

In brief, sterile beads were added to the samples, vortexed and processed routinely followed by centrifuged at 2000 rpm for 7 min. Specimens were then decontaminated by adding a 10% antibiotic mixture (Gibco, N.Y.USA) and incubating for 1 h at 4 °C. A volume of 200 μL of sample was inoculated into each of the following cell lines: MRC-5, HEp2, RD, MDCK, and LLCMK2 (ATCC, Manassas, VA, USA). One μΛ of maintenance medium (minimal essential medium with 1% fetal bovine serum) (Gibco, N.Y.USA) was added to each cell line and incubated at 37 °C for 14 days. The CPE was observed every other working day by inverted light microscopy (Olympus, Japan). After CPE appeared, cell smears were prepared and fixed in chilled acetone at −20 °C for 10 min and then tested by fluorescein-conjugated monoclonal antibody in a direct immunofluorescence assay (D^3^ Ultra 8^TM^ DFA Respiratory Virus Screening & ID Kit, Diagnostic Hybrids, USA). Stained cell smears were examined in a fluorescence microscope at 400× magnification (Olympus, Japan). Un-inoculated cell smear was used as negative control.

Reference standard {#Sec6}
------------------

To establish reference standards for RSV and hMPV viral load, we established 2 plasmid clones containing RSV nucleoprotein gene sequence and hMPV fusion protein gene sequence. These plasmids were amplified and cloned into a pCR® 2.1-TOPO® cloning vector using a TOPO TA cloning kit for sequencing (Invitrogen, Carlsbad, CA). Sequencing of the cloned insert established the fidelity of the sequence. Plasmid DNA containing each fragment sequence was purified, linearized by restriction enzyme digestion. The concentration of DNA was measured at least four times by a spectrophotometer (IMPLEN NanoPhotometer™, CA, USA), and the numbers of copies per μL were calculated using the mean values and the following formula: \[(g/μL DNA)/(length × 660)\] × 6.022 × 10^23^, where the length is the number of nucleotides. Tenfold dilutions equivalent to 10^2^ to 10^9^ copies/reaction of plasmid were used to determine the limit of detection (LOD) of the one-step triplex qRT-PCR assay.

Sample collection {#Sec7}
-----------------

This study included infants (\<24 months) and young children (\<6 years old) admitted to the pediatric department of Kaohsiung Chang Gung Memorial Hospital. Children and infants were eligible if identified as having one or more of the following symptoms: difficulty in breathing, nasal discharge, blocked nose, cough, or fast breathing for age. Nasopharyngeal aspirates were prospectively collected from November, 2010 to August, 2011. Informed consent was signed from the parent/guardian of each child. The nasopharyngeal aspirates (NPAs) were sent for virus isolation and identification. The RSV and hMPV were identified by using two methods in each individual sample. One was one-step triplex qRT-PCR, the other was immunofluorescence approach to confirm the virus etiology after CPE formation. Ethical approval for the study was obtained from the Chang Gung Memorial Hospital Ethics Committee (99-2746B).

Nucleic acid extraction and triplex RT-PCR (qRT-PCR) {#Sec8}
----------------------------------------------------

RNA was extracted from the supernatants of cultured viruses or nasopharyngeal aspirates by QIAamp viral RNA mini kit (Qiagen, Valencia, CA, USA) according to the manufactures instructions. All the RNA extraction procedure was conducted at BSL-2 laboratory. The qRT-PCR of a final concentration of 12.5 μL Master Mix and 0.625 μL Enzyme Mix (TaqManR RNA-to-CT™ *1-Step* Kit, Applied Biosystems), 400 nM each primer; 200 nM each probe, plus 7 μL of target RNA and was made up to a volume of 25 μL with nuclease free water (Promega Corp. Madison, USA). The reactions were incubated at 48 °C for 30 min, followed by 95 °C for 15 s (inactivation reverse transcriptase/activation Taq polymerase), 40 cycles of 95 °C for 15 s (denaturation), and 54 °C for 1 min (annealing). RT-PCR assays were performed on an ABI 7500-fast (Applied Biosystem). If Ct \>40 with lower concentration of virus, the amount of specimens was augmented for increasing the concentration of RNA and following One-step RT-PCR and direct sequencing.

Statistic analysis {#Sec9}
------------------

The sensitivity and specificity of triplex qRT-PCR results were analyzed by the receiver operating characteristic (ROC) method by SPSS software (SPSS statistical package version 17, SPSS Inc., Chicago, IL). The linearity and reproducibility for RSV and hMPV triplex qRT-PCR were analyzed by and linear regression and absolute quantification analysis (StepOnePlus software v2.3) provided by ABI 7500-fast PCR machine. Demographic data was analyzed by Student's "t" test and chi-square using SPSS software. A *p*-value \< 0.05 was considered significant.

Results {#Sec10}
=======

Assay specificity {#Sec11}
-----------------

A total of 86 virus culture stocks were used in specificity testing. The different virus etiology including RSV (*n =* 20), hMPV (*n =* 23), adenovirus (*n =* 10), enterovirus (*n =* 8), influenza A (*n =* 4), influenza B (*n =* 4), CMV (*n =* 5), HSV-1 (*n =* 3), parainfluenza type 1 (*n =* 3), parainfluenza type 2 (*n =* 3) and parainfluenza type 3(*n =* 3). No positive result was obtained for non-RSV or non-hMPV. We also used DEPC water as a negative control. The internal control and positive-control reactions were positive. Results showed that this one-step triplex qRT-PCR assay was specific and did not cross among RSV, hMPV and internal control GAPHD, with each other. Primer pair RSVF/RSVR and probe RSV-probe reacted only with RSV samples, whereas primers hMPVF/hMPVR and probe hMPV-probe allowed for the specific detection of hMPV isolates. The sensitivity and specificity of the one-step triplex qRT-PCR assay were both 100% when testing known viral stocks (Table [2](#Tab2){ref-type="table"}).Table 2Analytical sensitivity and specificity of triplex qRT-PCR assay in 86 known virus culture supernatantsVirus Culture StocksCultural Results No.(n)Triplex qRT-PCR Results (n)RSV+hMPV+RSV20200hMPV23023Adenovirus1000Enterovirus800Influenza A virus400Influenza B virus400CMV500HSV-1300Parainfluenza virus 1300Parainfluenza virus 2300Parainfluenza virus 3300Total86

Assay linearity {#Sec12}
---------------

Linearity of the one-step triplex qRT-PCR assay was determined using serial 10-fold dilutions of RSV and hMPV standard in viral transport medium (VTM) at the following concentrations:10^2^, 10^3^, 10^4^, 10^5^, 10^6^, 10^7^, 10^8^and 10^9^ copies/reaction. The extracted DNA was then analyzed by the triplex qRT-PCR assay. Three replicates were tested in a single run at each concentration. The relationship between the observed values and true concentrations of analyses was examined through linear regression. The limit of detection (LOD) of the triplex qRT-PCR assay was 100 copies/reaction. Linear regression analysis of the Ct values against the log10 RSV and hMPV plasmid concentration yielded R^2^ = 0.998 (Fig. [1a](#Fig1){ref-type="fig"}) and 0.992 (Fig. [1b](#Fig1){ref-type="fig"}), respectively. The detail statistic results were showed in Table [3](#Tab3){ref-type="table"}.Fig. 1Analytical sensitivity of triplex qRT-PCR assay. **a** hMPV and (**b**) RSV qRT-PCR assay. Fluorescence development was detected via real-time detection in triplex qRT-PCR run by using a dilution range of 10^9^--10^2^ DNA molecules/reaction of the hMPV and RSV molecular standards (Graph generated by ESE quant tube scanner studio software) Table 3The linearity data for RSV and hMPV triplex qRT-PCRTargetSlopeInterceptr^2^Linear range\
(copies/reaction)LOD^a^\
(copies/ reaction)hMPV−4.5745.190.99210^2^--10^9^100RSV−3.9144.850.99810^2^--10^9^100^a^Limit of detection

Assay precision {#Sec13}
---------------

Precision was estimated by performing the one-step triplex qRT-PCR assay twice per day (each run separated by a minimum of 2 h) over 2 days, by the same technician using the same equipment and reagent lot numbers. The intra-assay variation was assessed by testing 2 samples with different viral loads (10^8^ and 10^2^ copies/reaction) 3 times in a single run, while the inter-assay variation was assessed by testing the same samples 3 times in 2 separate runs. In our assay, the coefficient of variation (CV, express imprecision) was lower than 5%. The intra-assay CV ranged from 0.10 to 0.47%, while the inter-assay CV ranged from 0.23 to 1.04% (Table [4](#Tab4){ref-type="table"}).Table 4Reproducibility of the triplex qRT-PCR assayTargetConc. (copies/reaction)Number of determinationsMean CtSDCV (%)Intra-assayhMPV10^8^313.900.0330.2410^2^335.690.1700.47RSV10^8^315.800.0150.1010^2^339.100.1120.29Inter-assayhMPV10^8^613.890.0320.2310^2^636.460.8630.91RSV10^8^616.180.4301.0410^2^638.980.2250.58

Clinical evaluation {#Sec14}
-------------------

A total of 222 pediatric patients hospitalized with respiratory symptoms were enrolled from November 2010 through August 2011. Study patients were 61% male and 39% female with a mean age of 0.91 years old (ranges from32 days to 14 years old). The admitting diagnoses of these infants were bronchiolitis (58%), brochopneumonia (24%), and pneumonia (18%). Our one-step triplex qRT-PCR results showed that the viral load of the RSV or hMPV-positive samples from clinical specimens varied over a wide range, presenting threshold between Ct 21 and 44 (21 and 44 cycles). As a result, 68 specimens (30.6%) were found RSV positive, 18 specimens (8.1%) were found hMPV positive by our one-step triplex qRT-PCR. However, standard virus culture only detected 8 RSV positive cases (3.6%) and 0 hMPV cases (0%) (Table [5](#Tab5){ref-type="table"}). In detecting RSV, the major distribution of threshold cycles ranged between Ct 21 and 25 (1,035,656 copies/ reaction \~77,992 copies/reaction). In detecting hMPV, the major distribution of threshold cycles ranged between Ct 31 and 35 (8395 copies/ reaction \~476 copies/ reaction) (Fig. [2](#Fig2){ref-type="fig"}).Table 5Comparing of triplex qRT-PCR assay and virus culture in nasopharyngeal aspirates from 222 patients hospitalized with respiratory symptomsVirus Culture StocksCultural Results No.(n)Triplex qRT-PCR Results (n)RSV+hMPV+RSV880hMPV000Adenovirus1600Enterovirus800Influenza A virus100Influenza B virus100CMV300Parainfluenza virus 1300Parainfluenza virus 2100Parainfluenza virus 31300^a^NVI1686018Total2226818^a^ *NVI* Non virus identified using virus culture Fig. 2Ct values distribution of RSV and hMPV positive clinical specimens. Our one-step triplex qRT-PCR results showed that the viral load of the RSV or hMPV-positive samples from clinical specimens varied over a wide range, presenting threshold cycles between 21 and 44. RSV has a maximum occurrence detected between Ct 21 and 25, but hMPV has a maximum occurrence between Ct 31 and 35

qRT-PCR RSV positive patients were associated with increased severe inflammation and pneumonia {#Sec15}
----------------------------------------------------------------------------------------------

The demographic data based on RSV/hMPV one-step triplex qRT-PCR detection in 222 infants hospitalized with respiratory symptoms showed that male patients have higher percentages in RSV or hMPV infection. RSV and hMPV infection cases were significantly associated with severe lung inflammation based on chest X-Ray index. Complication of pneumonia was observed in more than 90% of RSV or hMPV infection patient (Table [6](#Tab6){ref-type="table"}). In addition, we found that RSV or hMPV infection is not associated with C-reactive protein level, indicating the importance of making definite diagnosis in early intervention of RSV and hMPV associated adverse effects, such as severe inflammation and pneumonia.Table 6Demographic and clinical characteristics from 222 patients hospitalized with respiratory symptomsTriplex qRT-PCR Results*P*-valueNegative(*n =* 136)RSV+ (*n =* 68)hMPV+ (*n =* 18)Gender (%) F62(45.6)22(32.4)3(16.7)0.030\* M74(54.4)46(67.6)15(83.3)Age (years-old)1.38 ± 1.891.15 ± 1.221.00 ± 1.290.119CXR index (%) N/A27(19.9)3(4.4)4(22.2)0.008\* Mild inflammation43(31.618(26.5)4(22.2) Severe inflammation66(48.5)47(69.1)10(55.6)ICU treatment (%) No77(56.6)47(69.1)12(66.7)0.118 Yes59(43.4)21(30.9)6(33.3)Pneumonia (%) No95(69.9)6(8.8)1(5.6)0.001\* Yes41(30.1)62(91.2)17(94.4)Hypersomina (%) No131(96.3)65(95.6)18(100)0.621 Yes5(3.7)3(4.4)0(0)Intubation (%) No134(98.5)67(98.5)17(94.4)0.599 Yes2(1.5)1(1.5)1(5.6)CRP index (%) N/A8(5.9)3(4.4)0(0)0.938  \< 562(45.6)34(50.5)6(33.3) Positive66(48.5)31(45.6)12(66.7)*N/A* not available, *CXR index* Chest X-Ray index, *ICU* Intensive care unit, *CRP* C-reactive protein\**P* \< 0.05

Discussion {#Sec16}
==========

In this study, we established a rapid and internally controlled triplex qRT-PCR assay that can identify RSV and hMPV virus in one reaction mixtures. The validation parameters described here were in accordance with procedural and statistical methods as recommended in the Validation of Analytical Procedures (Clinical and laboratory standard institute, CLSI 2009). The development of fluorescent methods and instruments that allow real-time monitoring of the amplification process is considered an important step for molecular biology \[[@CR19]\]. Real-time RT-PCR has become a well-established procedure in terms of rapid detection of nucleic acid targets. Incorporation of housekeeping genes as internal control is important to exclude false negative results due to incomplete RNA extraction or inhibition of PCR. The optimized assays reported here, allow specific and sensitive detection of RSV and hMPV, as well as of an internal amplification control. Furthermore, this method can be multiplexed using different fluorogenic dyes for the three probes.

In this current study, we determined the copy numbers of RSV and hMPV and internal control (GAPDH) at the same time in one test sample. The procedures of RNA extraction and reagent preparation and efficiency of instruments could be monitor by triplex qRT-PCR in one sample. Furthermore, this approach also reduced the results of "false-negative" and cost down. However, some groups detected target virus and internal control by using duplex qRT-PCR that may increase the time-consuming \[[@CR20]\].

This triplex qRT-PCR provides several clinical advantages. First, this method saves the time for diagnostic performance, compared to virus culture. Second, our method increased the accuracy of RSV and hMPV detection. The rapid and accurate RSV and hMPV detection may help for early intervention of the related clinical events or complications, such as severe lung inflammation and pneumonia.

Conclusion {#Sec17}
==========

Altogether, the three sets of primer/probe in the one-step triplex qRT-PCR assay presented in this study is a specific and sensitive diagnostic tool to rapid screening for the detection of RSV and hMPV RNA. It is useful method in routine laboratory diagnostics.

CPE

:   Cytopathic effect

hMPV

:   Human metapneumovirus

LOD

:   Limit of detection

NPAs

:   Nasopharyngeal aspirates

RSV

:   Respiratory syncytial virus

RTI

:   Respiratory tract infection
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